Endometrial Cancer Trial, Recruiting (NCT06230549)

Endometrial Cancer Trial, Recruiting NCT06230549 Sponsor: University Hospital, Essen Condition: Endometrial Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06230549 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Endometrial Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have a good general level of physical fitness and are able to carry out normal daily activities with little or no limitation (this is measured using a scale called ECOG, scored 0 or 1)
Your diagnosis has been confirmed by a tissue sample (biopsy) examined under a microscope, and you have had an MRI scan of the pelvis to determine the stage of your condition

Who may not be able to join:

Your disease has come back after previous treatment (recurrent disease)
You have previously had radiotherapy (radiation treatment) to the pelvic area
Your cancer has spread to distant parts of the body, as shown by imaging or other tests (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 2 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06230549

Sponsor: University Hospital, Essen

Phase: Not Applicable

Status: Recruiting

Condition: Endometrial Cancer

More information: https://clinicaltrials.gov/study/NCT06230549

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have a good general level of physical fitness and are able to carry out normal daily activities with little or no limitation (this is measured using a scale called ECOG, scored 0 or 1)
Your diagnosis has been confirmed by a tissue sample (biopsy) examined under a microscope, and you have had an MRI scan of the pelvis to determine the stage of your condition

Who may not be able to join:

Your disease has come back after previous treatment (recurrent disease)
You have previously had radiotherapy (radiation treatment) to the pelvic area
Your cancer has spread to distant parts of the body, as shown by imaging or other tests (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 2 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University Hospital, Essen

Registry

ClinicalTrials.gov

Start date

15 January 2024

Est. completion

15 December 2024

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

Rectal Toxicity; Bladder Toxicity; Skin Toxicity; Lymph-Edema grade

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov